The ErbB family of RTKs are implicated in multiple cancer types via dysregulation of pathways involved in oncogenic processes such as epithelial–mesenchymal transition (EMT), tumour invasion and cell migration.10 The gene discussed is EGFR; the disease is neoplasm.